Aspen Pharmacare (APNJ.J) has wrapped up pacts to secure funding of $30 million from the Gates Foundation and the Coalition for Epidemic Preparedness Innovations to help make affordable vaccines for Africa, the company said.
In August, Aspen announced a deal with the Serum Institute of India to make and sell four Aspen-branded vaccines for Africa, as it looks to use its near-idle COVID-19 vaccine production lines in South Africa. It had been negotiating with the two organizations for grant funding.
The Serum Institute agreement provides for Aspen to make and distribute pneumococcal, rotavirus, polyvalent meningococcal and hexavalent vaccines commonly administered in Africa.
